Elizabeth S. Yeh, Ph.D. - Publications

2004 Duke University, Durham, NC 
cell signaling cascades that regulate cell proliferation, differentiation or function

8/33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Yeh ES, Belka GK, Vernon AE, Chen CC, Jung JJ, Chodosh LA. Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of Pten. Proceedings of the National Academy of Sciences of the United States of America. 110: 6103-8. PMID 23520049 DOI: 10.1073/pnas.1217415110  1
2012 Alvarez JV, Yeh ES, Feng Y, Chodosh LA. Oncogene addiction: Mouse models and clinical relevance for molecularly targeted therapies Genetically Engineered Mice For Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing. 527-547. DOI: 10.1007/978-0-387-69805-2_25  1
2011 Yeh ES, Yang TW, Jung JJ, Gardner HP, Cardiff RD, Chodosh LA. Hunk is required for HER2/neu-induced mammary tumorigenesis. The Journal of Clinical Investigation. 121: 866-79. PMID 21393859 DOI: 10.1172/JCI42928  1
2007 Yeh ES, Means AR. PIN1, the cell cycle and cancer. Nature Reviews. Cancer. 7: 381-8. PMID 17410202 DOI: 10.1038/nrc2107  1
2006 van Drogen F, Sangfelt O, Malyukova A, Matskova L, Yeh E, Means AR, Reed SI. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Molecular Cell. 23: 37-48. PMID 16818231 DOI: 10.1016/j.molcel.2006.05.020  1
2006 Yeh ES, Lew BO, Means AR. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability. The Journal of Biological Chemistry. 281: 241-51. PMID 16223725 DOI: 10.1074/jbc.M505770200  1
2004 Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nature Cell Biology. 6: 308-18. PMID 15048125 DOI: 10.1038/ncb1110  1
2003 Joseph JD, Yeh ES, Swenson KI, Means AR, Winkler. The peptidyl-prolyl isomerase Pin1. Progress in Cell Cycle Research. 5: 477-87. PMID 14593743  1
Low-probability matches
2019 Zambrano JN, Eblen ST, Abt M, Rhett JM, Muise-Helmericks R, Yeh ES. HUNK Phosphorylates Rubicon to Support Autophagy. International Journal of Molecular Sciences. 20. PMID 31752345 DOI: 10.3390/ijms20225813  0.01
2019 Williams CB, Phelps-Polirer K, Dingle IP, Williams CJ, Rhett MJ, Eblen ST, Armeson K, Hill EG, Yeh ES. HUNK phosphorylates EGFR to regulate breast cancer metastasis. Oncogene. PMID 31597954 DOI: 10.1038/s41388-019-1046-5  0.01
2019 Sun B, Mason S, Wilson RC, Hazard SE, Wang Y, Fang R, Wang Q, Yeh ES, Yang M, Roberts TM, Zhao JJ, Wang Q. Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers. Oncogene. PMID 31462705 DOI: 10.1038/s41388-019-0953-9  0.01
2019 Rycenga HB, Wolfe KB, Yeh ES, Long DT. Uncoupling of p97 ATPase activity has a dominant negative effect on protein extraction. Scientific Reports. 9: 10329. PMID 31316150 DOI: 10.1038/s41598-019-46949-4  0.01
2019 Herrera H, Dilday T, Uber A, Scott D, Zambrano JN, Wang M, Angel PM, Mehta AS, Drake RR, Hill EG, Yeh ES. Core-Fucosylated Tetra-Antennary -Glycan Containing A Single -Acetyllactosamine Branch Is Associated with Poor Survival Outcome in Breast Cancer. International Journal of Molecular Sciences. 20. PMID 31126011 DOI: 10.3390/ijms20102528  0.01
2019 Rutkovsky AC, Yeh ES, Guest ST, Findlay VJ, Muise-Helmericks RC, Armeson K, Ethier SP. Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer. Bmc Cancer. 19: 491. PMID 31122207 DOI: 10.1186/s12885-019-5667-4  0.01
2018 Zambrano JN, Williams CJ, Williams CB, Hedgepeth L, Burger P, Dilday T, Eblen ST, Armeson K, Hill EG, Yeh ES. Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase. Oncotarget. 9: 35962-35973. PMID 30542510 DOI: 10.18632/oncotarget.26311  0.01
2018 Rhett JM, Yeh ES. The Potential for Connexin Hemichannels to Drive Breast Cancer Progression through Regulation of the Inflammatory Response. International Journal of Molecular Sciences. 19. PMID 29601539 DOI: 10.3390/ijms19041043  0.01
2017 Yeh ES, Williams CJ, Williams CB, Bonilla IV, Klauber-DeMore N, Phillips SL. Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration. Oncotarget. 8: 109358-109369. PMID 29312613 DOI: 10.18632/oncotarget.22678  0.01
2017 Phillips SL, Williams CB, Zambrano JN, Williams CJ, Yeh ES. Connexin 43 in the development and progression of breast cancer: What's the connection? (Review). International Journal of Oncology. PMID 28902343 DOI: 10.3892/ijo.2017.4114  0.01
2017 Mesnil M, Aasen T, Boucher J, Chépied A, Cronier L, Defamie N, Kameritsch P, Laird DW, Lampe PD, Lathia JD, Leithe E, Mehta PP, Monvoisin A, Pogoda K, Sin WC, ... ... Yeh ES, et al. An update on minding the gap in cancer. Biochimica Et Biophysica Acta. PMID 28655619 DOI: 10.1016/j.bbamem.2017.06.015  0.01
2017 Zambrano JN, Neely BA, Yeh ES. Hormonally Up-regulated Neu-associated Kinase: A novel target for breast cancer progression. Pharmacological Research. PMID 28189783 DOI: 10.1016/j.phrs.2017.02.007  0.01
2016 Phelps-Polirer K, Abt MA, Smith D, Yeh ES. Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer. Plos One. 11: e0153025. PMID 27045589 DOI: 10.1371/journal.pone.0153025  0.01
2016 Williams CB, Yeh ES, Soloff AC. Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. Npj Breast Cancer. 2. PMID 26998515 DOI: 10.1038/npjbcancer.2015.25  0.01
2016 Zambrano J, Yeh ES. Autophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast Cancer. Breast Cancer : Basic and Clinical Research. 10: 13-23. PMID 26997868 DOI: 10.4137/BCBCR.S32791  0.01
2016 Grek CL, Rhett JM, Bruce JS, Ghatnekar GS, Yeh ES. Connexin 43, breast cancer tumor suppressor: missed connections? Cancer Letters. PMID 26884256 DOI: 10.1016/j.canlet.2016.02.008  0.01
2016 Abt MA, Grek CL, Ghatnekar GS, Yeh ES. Evaluation of Lung Metastasis in Mouse Mammary Tumor Models by Quantitative Real-time PCR. Journal of Visualized Experiments : Jove. PMID 26862835 DOI: 10.3791/53329  0.01
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Yeh ES, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.01
2015 Williams CB, Soloff AC, Ethier SP, Yeh ES. Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-Negative Breast Cancer: Ligand-Mediated Mechanisms of Receptor Regulation and Potential for Clinical Targeting. Advances in Cancer Research. 127: 253-81. PMID 26093903 DOI: 10.1016/bs.acr.2015.04.008  0.01
2015 Grek CL, Rhett JM, Bruce JS, Abt MA, Ghatnekar GS, Yeh ES. Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1. Bmc Cancer. 15: 296. PMID 25881004 DOI: 10.1186/s12885-015-1229-6  0.01
2015 Yeh ES, Abt MA, Hill EG. Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors. Breast Cancer Research and Treatment. 149: 91-8. PMID 25515931 DOI: 10.1007/s10549-014-3227-9  0.01
2014 Yeh ES, Vernon-Grey A, Martin H, Chodosh LA. Tetracycline-regulated mouse models of cancer. Cold Spring Harbor Protocols. 2014: pdb.top069823. PMID 25275112 DOI: 10.1101/pdb.top069823  0.01
2011 Yeh ES, Rochette LM, McKenzie LB, Smith GA. Injuries associated with cribs, playpens, and bassinets among young children in the US, 1990-2008. Pediatrics. 127: 479-86. PMID 21330418 DOI: 10.1542/peds.2010-1537  0.01
1980 Cullen WR, Einstein FWB, Huang CH, Willis AC, Yeh ES. Asymmetric hydrogenation catalyzed by cationic ferrocenylphosphine rhodium(I) complexes and the crystal structure of a catalyst precursor Journal of the American Chemical Society. 102: 988-993.  0.01
1977 Cullen WR, Yeh ES. Asymmetric hydrogenation using ferrocenylphosphine rhodium(I) cationic complexes Journal of Organometallic Chemistry. 139: C13-C16. DOI: 10.1016/S0022-328X(00)84313-2  0.01
Hide low-probability matches.